Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Federal Trade Commission
Cipla
Chinese Patent Office
McKinsey
Dow
Cerilliant
Teva

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201849

« Back to Dashboard

NDA 201849 describes GLUCAGON, which is a drug marketed by Lilly and Fresenius Kabi Usa and is included in three NDAs. It is available from four suppliers. Additional details are available on the GLUCAGON profile page.

The generic ingredient in GLUCAGON is glucagon recombinant. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glucagon recombinant profile page.
Summary for 201849
Tradename:GLUCAGON
Applicant:Fresenius Kabi Usa
Ingredient:glucagon hydrochloride
Patents:0
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 201849
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GLUCAGON glucagon hydrochloride POWDER;INTRAMUSCULAR, INTRAVENOUS 201849 NDA Fresenius Kabi USA, LLC 63323-593 N 63323-593-03
GLUCAGON glucagon hydrochloride POWDER;INTRAMUSCULAR, INTRAVENOUS 201849 NDA Fresenius Kabi USA, LLC 63323-596 N 63323-596-13

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INTRAMUSCULAR, INTRAVENOUSStrengthEQ 1MG BASE/VIAL
Approval Date:May 8, 2015TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Moodys
Chinese Patent Office
Citi
Accenture
Mallinckrodt
Cantor Fitzgerald
Baxter
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.